In September, Cyclotek (Aust) Pty Ltd, a commercial partner of the CRC for Biomedical Imaging Development Ltd, provided a radiopharmaceutical tracer for use internationally in a medical procedure.  This first-time supply has helped a New Zealand patient with a brain tumour have earlier treatment.  The use of the tracer allowed the doctors to more closely identify the location, nature and size of the tumour, when several other high-level neurological diagnostic tests had not provided enough information for a clear treatment plan to proceed

Media release -  International_supply_of_radiotracer_for_cancer_patient.pdf